An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic-Reference-Cited by-同舟云学术

An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic

Published:2007-12-03 Issue:12 Volume:117 Page:4044-4054
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Fernández Ariel,Sanguino Angela,Peng Zhenghong,Ozturk Eylem,Chen Jianping,Crespo Alejandro,Wulf Sarah,Shavrin Aleksander,Qin Chaoping,Ma Jianpeng,Trent Jonathan,Lin Yvonne,Han Hee-Dong,Mangala Lingegowda S.,Bankson James A.,Gelovani Juri,Samarel Allen,Bornmann William,Sood Anil K.,Lopez-Berestein Gabriel

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference34 articles.

1. Issues and progress with protein kinase inhibitors for cancer treatment

2. Tyrosine Kinase Inhibition: An Approach to Drug Development

3. TYROSINE KINASE INHIBITORS AND THE DAWN OF MOLECULAR CANCER THERAPEUTICS

4. Pharmaceutical research in molecular oncology

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitor design for TMPRSS2: insights from computational analysis of its backbone hydrogen bonds using a simple descriptor;European Biophysics Journal;2023-12-29

2. Cardiotoxicity;Side Effects of Cancer Therapy;2023-12-11

3. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine;Current Issues in Molecular Biology;2023-10-15

4. Mitochondrial Dysfunction in Cardiotoxicity Induced by BCR-ABL1 Tyrosine Kinase Inhibitors -Underlying Mechanisms, Detection, Potential Therapies;Cardiovascular Toxicology;2023-07-21

5. Cardiotoxicity of Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients;Hemato;2023-02-27